المؤلفون: Nese Saltoglu, Ziya Kuruüzüm, Nesrin Türker, Petek Konya, Alper Şener, Uluhan Yıldız, Gunay Tuncer Ertem, Kaya Suer, Bilgehan Aygen, Hüseyin Bilgin, Dilara Inan, Onur Ural, Bahar Ormen, Nazlim Aktug Demir, Sumeyra Simsek, Orhan Yildiz, Reşit Mistik, Hüseyin Tarakçı, Nurhan Doğan, Pinar Korkmaz, Rıza Aytaç Çetinkaya, Emine Türkoğlu, Deniz Kamalak Güzel, Gülden Ersöz, Neşe Demirtürk, Ismail Necati Hakyemez, Yunus Gürbüz, Faruk Karakeçili, Necla Tulek, Sami Kinikli, Atahan Cagatay, Nazan Tuna, Ayse Batirel, Ali Asan, İlhami Çelik, Mustafa Kemal Çelen, Sener Barut, Selcan Arslan Ozel, Funda Şimşek, Sıla Akhan, Sinan Ozturk

المساهمون: Demirtürk, Neşe, Türkoğlu, Emine, Doğan, Nurhan, Dicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalı, Çelen, Mustafa Kemal

المصدر: Turk J Gastroenterol

مصطلحات موضوعية: Ledipasvir, medicine.medical_specialty, Sofosbuvir, Side effect, Turkey, Genotype, Hepacivirus, Chronic hepatitis C, Antiviral Agents, chemistry.chemical_compound, Internal medicine, Ribavirin, Medicine, Humans, Infectious disease (athletes), Adverse effect, Fluorenes, business.industry, Gastroenterology, Hepatitis C, Chronic, Hepatitis C, Real-world data, Discontinuation, Sustained virological response, Treatment Outcome, chemistry, Original Article, Benzimidazoles, Drug Therapy, Combination, Female, business, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e602ab0c0b847453658a32ab997f995
https://avesis.deu.edu.tr/publication/details/87c1a8ca-205a-4345-87a2-a55ba3159476/oai